Piceatannol and epicatechin had good binding affinity with CD36 (docking score < -5 kcal/mol), and piceatannol treatment or epicatechin treatment inhibited the proliferation and inflammation of RA-FLS and induced cell cycle arrest and apoptosis (P < 0.05). The gene discussed is CD36; the disease is rheumatoid arthritis.